TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2026
Back to search
Official data from USPTO
KYVERNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
07/18/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/02/2019
Registration date
11/14/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
07/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/19/2023
First use in commerce
09/19/2023
Drawing code
4
Owner type
03
Owner location
Emeryville, CA, US
Examiner
SNYDER, NELSON B
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc.
Representatives
Lisa Greenwald-Swire FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy productsgenetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Publications
History of USPTO decisions and trademark events.
60 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/17/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/17/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/06/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/26/2023
IUAF
USE AMENDMENT FILED
09/22/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2023
EX5G
SOU EXTENSION 5 GRANTED
03/29/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/29/2023
EXT5
SOU EXTENSION 5 FILED
03/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/23/2022
EX4G
SOU EXTENSION 4 GRANTED
08/19/2022
EXT4
SOU EXTENSION 4 FILED
08/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/08/2022
EX3G
SOU EXTENSION 3 GRANTED
02/04/2022
EXT3
SOU EXTENSION 3 FILED
02/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/18/2021
EX2G
SOU EXTENSION 2 GRANTED
08/16/2021
EXT2
SOU EXTENSION 2 FILED
08/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/13/2021
EX1G
SOU EXTENSION 1 GRANTED
03/11/2021
EXT1
SOU EXTENSION 1 FILED
03/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/11/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/28/2020
PUBO
PUBLISHED FOR OPPOSITION
07/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/18/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/18/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/18/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/18/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2020
ALIE
ASSIGNED TO LIE
06/11/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/03/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/02/2020
GNFR
FINAL REFUSAL E-MAILED
06/02/2020
CNFR
FINAL REFUSAL WRITTEN
06/02/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/14/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/14/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2020
GNRT
NON-FINAL ACTION E-MAILED
01/07/2020
CNRT
NON-FINAL ACTION WRITTEN
01/07/2020
DOCK
ASSIGNED TO EXAMINER
01/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2019
NWAP
NEW APPLICATION ENTERED
10/05/2019
Continuous trademark protection
Get notified about every new filing that threatens KYVERNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.